vs

Side-by-side financial comparison of PATRICK INDUSTRIES INC (PATK) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $924.2M, roughly 1.2× PATRICK INDUSTRIES INC). PATRICK INDUSTRIES INC runs the higher net margin — 3.1% vs -127.8%, a 130.9% gap on every dollar of revenue. On growth, PATRICK INDUSTRIES INC posted the faster year-over-year revenue change (9.2% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $112.7M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -0.5%).

Anduril Industries, Inc. is an American defense technology company specializing in the development of advanced autonomous systems.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

PATK vs PRGO — Head-to-Head

Bigger by revenue
PRGO
PRGO
1.2× larger
PRGO
$1.1B
$924.2M
PATK
Growing faster (revenue YoY)
PATK
PATK
+11.7% gap
PATK
9.2%
-2.5%
PRGO
Higher net margin
PATK
PATK
130.9% more per $
PATK
3.1%
-127.8%
PRGO
More free cash flow
PRGO
PRGO
$35.9M more FCF
PRGO
$148.6M
$112.7M
PATK
Faster 2-yr revenue CAGR
PRGO
PRGO
Annualised
PRGO
1.3%
-0.5%
PATK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PATK
PATK
PRGO
PRGO
Revenue
$924.2M
$1.1B
Net Profit
$29.1M
$-1.4B
Gross Margin
23.0%
32.6%
Operating Margin
6.2%
-116.0%
Net Margin
3.1%
-127.8%
Revenue YoY
9.2%
-2.5%
Net Profit YoY
99.7%
-3093.9%
EPS (diluted)
$0.82
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PATK
PATK
PRGO
PRGO
Q4 25
$924.2M
$1.1B
Q3 25
$975.6M
$1.0B
Q2 25
$1.0B
$1.1B
Q1 25
$1.0B
$1.0B
Q4 24
$846.1M
$1.1B
Q3 24
$919.4M
$1.1B
Q2 24
$1.0B
$1.1B
Q1 24
$933.5M
$1.1B
Net Profit
PATK
PATK
PRGO
PRGO
Q4 25
$29.1M
$-1.4B
Q3 25
$35.3M
$7.5M
Q2 25
$32.4M
$-8.4M
Q1 25
$38.2M
$-6.4M
Q4 24
$14.6M
$-44.4M
Q3 24
$40.9M
$-21.0M
Q2 24
$47.9M
$-108.4M
Q1 24
$35.1M
$2.0M
Gross Margin
PATK
PATK
PRGO
PRGO
Q4 25
23.0%
32.6%
Q3 25
22.6%
36.1%
Q2 25
23.9%
34.4%
Q1 25
22.8%
37.6%
Q4 24
22.1%
33.9%
Q3 24
23.1%
37.2%
Q2 24
22.8%
37.0%
Q1 24
21.9%
33.1%
Operating Margin
PATK
PATK
PRGO
PRGO
Q4 25
6.2%
-116.0%
Q3 25
6.8%
7.0%
Q2 25
8.3%
4.3%
Q1 25
6.5%
4.5%
Q4 24
4.7%
10.0%
Q3 24
8.1%
7.4%
Q2 24
8.3%
-2.5%
Q1 24
6.4%
-5.1%
Net Margin
PATK
PATK
PRGO
PRGO
Q4 25
3.1%
-127.8%
Q3 25
3.6%
0.7%
Q2 25
3.1%
-0.8%
Q1 25
3.8%
-0.6%
Q4 24
1.7%
-3.9%
Q3 24
4.4%
-1.9%
Q2 24
4.7%
-10.2%
Q1 24
3.8%
0.2%
EPS (diluted)
PATK
PATK
PRGO
PRGO
Q4 25
$0.82
$-10.23
Q3 25
$1.01
$0.05
Q2 25
$0.96
$-0.06
Q1 25
$1.11
$-0.05
Q4 24
$-1.44
$-0.32
Q3 24
$1.80
$-0.15
Q2 24
$2.16
$-0.79
Q1 24
$1.59
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PATK
PATK
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$26.4M
Total DebtLower is stronger
$1.3B
Stockholders' EquityBook value
$1.2B
$2.9B
Total Assets
$3.1B
$8.5B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PATK
PATK
PRGO
PRGO
Q4 25
$26.4M
Q3 25
$20.7M
$432.1M
Q2 25
$22.0M
$454.2M
Q1 25
$86.6M
$409.9M
Q4 24
$33.6M
$558.8M
Q3 24
$52.6M
$1.5B
Q2 24
$44.0M
$542.8M
Q1 24
$17.6M
$658.5M
Total Debt
PATK
PATK
PRGO
PRGO
Q4 25
$1.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PATK
PATK
PRGO
PRGO
Q4 25
$1.2B
$2.9B
Q3 25
$1.2B
$4.4B
Q2 25
$1.1B
$4.5B
Q1 25
$1.1B
$4.4B
Q4 24
$1.1B
$4.3B
Q3 24
$1.1B
$4.6B
Q2 24
$1.1B
$4.5B
Q1 24
$1.1B
$4.7B
Total Assets
PATK
PATK
PRGO
PRGO
Q4 25
$3.1B
$8.5B
Q3 25
$3.1B
$10.1B
Q2 25
$3.1B
$10.1B
Q1 25
$3.2B
$9.8B
Q4 24
$3.0B
$9.6B
Q3 24
$3.1B
$11.2B
Q2 24
$3.0B
$10.4B
Q1 24
$3.0B
$10.6B
Debt / Equity
PATK
PATK
PRGO
PRGO
Q4 25
1.10×
Q3 25
Q2 25
Q1 25
Q4 24
1.18×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PATK
PATK
PRGO
PRGO
Operating Cash FlowLast quarter
$130.8M
$175.4M
Free Cash FlowOCF − Capex
$112.7M
$148.6M
FCF MarginFCF / Revenue
12.2%
13.4%
Capex IntensityCapex / Revenue
2.0%
2.4%
Cash ConversionOCF / Net Profit
4.50×
TTM Free Cash FlowTrailing 4 quarters
$246.5M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PATK
PATK
PRGO
PRGO
Q4 25
$130.8M
$175.4M
Q3 25
$9.1M
$51.7M
Q2 25
$149.4M
$75.9M
Q1 25
$40.1M
$-64.5M
Q4 24
$102.7M
$312.6M
Q3 24
$51.5M
$42.2M
Q2 24
$137.5M
$9.5M
Q1 24
$35.2M
$-1.4M
Free Cash Flow
PATK
PATK
PRGO
PRGO
Q4 25
$112.7M
$148.6M
Q3 25
$-17.2M
$29.8M
Q2 25
$131.1M
$56.7M
Q1 25
$19.9M
$-90.0M
Q4 24
$77.2M
$274.9M
Q3 24
$33.7M
$15.1M
Q2 24
$120.6M
$-18.9M
Q1 24
$19.7M
$-26.5M
FCF Margin
PATK
PATK
PRGO
PRGO
Q4 25
12.2%
13.4%
Q3 25
-1.8%
2.9%
Q2 25
12.5%
5.4%
Q1 25
2.0%
-8.6%
Q4 24
9.1%
24.2%
Q3 24
3.7%
1.4%
Q2 24
11.9%
-1.8%
Q1 24
2.1%
-2.4%
Capex Intensity
PATK
PATK
PRGO
PRGO
Q4 25
2.0%
2.4%
Q3 25
2.7%
2.1%
Q2 25
1.7%
1.8%
Q1 25
2.0%
2.4%
Q4 24
3.0%
3.3%
Q3 24
1.9%
2.5%
Q2 24
1.7%
2.7%
Q1 24
1.7%
2.3%
Cash Conversion
PATK
PATK
PRGO
PRGO
Q4 25
4.50×
Q3 25
0.26×
6.89×
Q2 25
4.61×
Q1 25
1.05×
Q4 24
7.05×
Q3 24
1.26×
Q2 24
2.87×
Q1 24
1.00×
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PATK
PATK

Recreational Vehicle$276.3M30%
Distribution$222.4M24%
Marine$141.9M15%
Industrial$110.8M12%
Powersports$104.8M11%
Manufactured Housing$67.9M7%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons